Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| TuHURA Biosciences, Inc./NV | 3,519,170 | reported | 08 Nov 2021 | tx 10+4,129,737−200,000 |
| North Horizon, Inc. | 2,500,000 | reported | 06 Sept 2016 | tx 1+2,500,000 |
| HERON THERAPEUTICS, INC. /DE/ | 100,000 | reported | 19 Dec 2019 | tx 10+388,947−60,000 |
| ARENA PHARMACEUTICALS INC | 58,074 | reported | 15 Dec 2014 | tx 39+1,042,556−279,050 |
| TELIK INC | 50,000 | reported | 19 May 2017 | tx 12+219,660−12,960 |
| Kura Oncology, Inc. | 23,000 | reported | 22 Jun 2021 | tx 7+122,000 |
| Versartis, Inc. | 7,500 | reported | 12 Sept 2019 | tx 5+31,876 |
| CombiMatrix Corp | 0 | reported | 14 Nov 2017 | tx 12+65,064−8,619 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 08 Nov 2021 | GRANT_AWARD | TuHURA Biosciences, Inc./NV | 3,519,170 | 0.00 USD | deriv |
| 22 Sept 2021 | GRANT_AWARD | TuHURA Biosciences, Inc./NV | 100,000 | 0.00 USD | deriv |
| 22 Jun 2021 | GRANT_AWARD | Kura Oncology, Inc. | 23,000 | 0.00 USD | deriv |
| 15 Sept 2020 | GRANT_AWARD | TuHURA Biosciences, Inc./NV | 120,000 | 0.00 USD | deriv |
| 26 Jun 2020 | GRANT_AWARD | TuHURA Biosciences, Inc./NV | 39,567 | 0.00 USD | deriv |
| 24 Jun 2020 | GRANT_AWARD | Kura Oncology, Inc. | 23,000 | 0.00 USD | deriv |
| 19 Dec 2019 | GRANT_AWARD | HERON THERAPEUTICS, INC. /DE/ | 100,000 | 0.00 USD | deriv |
| 12 Sept 2019 | GRANT_AWARD | Versartis, Inc. | 7,500 | 0.00 USD | deriv |
| 05 Sept 2019 | GRANT_AWARD | TuHURA Biosciences, Inc./NV | 39,567 | 0.00 USD | deriv |
| 05 Sept 2019 | GRANT_AWARD | TuHURA Biosciences, Inc./NV | 35,433 | 0.00 USD | deriv |
| 25 Jun 2019 | GRANT_AWARD | Kura Oncology, Inc. | 13,000 | 0.00 USD | deriv |
| 30 Apr 2019 | OTHER | TuHURA Biosciences, Inc./NV | 200,000 | 0.00 USD | deriv |
| 03 Jan 2019 | GRANT_AWARD | Versartis, Inc. | 4,688 | 0.00 USD | deriv |
| 03 Jan 2019 | GRANT_AWARD | Versartis, Inc. | 7,500 | 0.00 USD | deriv |
| 15 Dec 2018 | GRANT_AWARD | HERON THERAPEUTICS, INC. /DE/ | 71,000 | 0.00 USD | deriv |
| 08 Nov 2018 | GRANT_AWARD | TuHURA Biosciences, Inc./NV | 40,000 | 0.00 USD | deriv |
| 02 Jul 2018 | SALE | HERON THERAPEUTICS, INC. /DE/ | 1,060 | 38.80 USD | |
| 30 Apr 2018 | OTHER | HERON THERAPEUTICS, INC. /DE/ | 744 | 13.22 USD | |
| 02 Jul 2018 | EXERCISE | HERON THERAPEUTICS, INC. /DE/ | 30,000 | 15.30 USD | |
| 02 Jul 2018 | SALE | HERON THERAPEUTICS, INC. /DE/ | 28,940 | 38.15 USD | |
| 02 Jul 2018 | EXERCISE | HERON THERAPEUTICS, INC. /DE/ | 30,000 | 0.00 USD | deriv |
| 07 Jun 2018 | GRANT_AWARD | Kura Oncology, Inc. | 13,000 | 0.00 USD | deriv |
| 13 Apr 2018 | GRANT_AWARD | TuHURA Biosciences, Inc./NV | 200,000 | 0.00 USD | deriv |
| 13 Apr 2018 | GRANT_AWARD | TuHURA Biosciences, Inc./NV | 36,000 | 0.00 USD | deriv |
| 31 Oct 2017 | OTHER | HERON THERAPEUTICS, INC. /DE/ | 536 | 13.05 USD |
1 purchase reported after at least 12 months of silence — most recent on 10 May 2016.